Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 602 clinical trials
Multicenter Study on Laparoscopic Total Gastrectomy for Advanced Gastric Cancer

patients with locally advanced gastric cancer (clinical stage T2-4aN0-3M0). The primary purpose of this study is to evaluate the overall survival and determine the efficacy of LTG compared with OTG for

  • 0 views
  • 05 Mar, 2021
  • 1 location
Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial (PLATFORM)

To evaluate the efficacy of maintenance therapies following completion of standard first-line chemotherapy in patients with locally advanced or metastatic HER-2 positive or HER-2 negative oesophago-gastric adenocarcinomas.

erbb2
ramucirumab
adenocarcinoma
blood transfusion
cancer
  • 0 views
  • 26 Jan, 2022
  • 1 location
RCT of Gastric ESD With or Without Epineprhine Added Solution

This is an international multi-center randomised controlled study comparing outcomes of gastric endoscopic submucosal dissection (ESD) with or without addition of epinephrine in the submucosal injection solution.

epinephrine
endoscopic submucosal dissection
  • 6 views
  • 19 Feb, 2022
  • 1 location
XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)

Our study aims to compare the efficacy and safety of capecitabine and oxaliplatin for 4 months versus 6 months as adjuvant chemotherapy after D2 Gastrectomy in patients with gastric cancer.

oxaliplatin
capecitabine
immunostimulants
gastrectomy
adjuvant chemotherapy
  • 33 views
  • 22 Jan, 2021
  • 10 locations
Neoadjuvant Chemoradiotherapy vs. Chemotherapy With Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer

Patients with histologically confirmed gastric adenocarcinoma with locally advanced gastric cancer are randomized in a 1:1 ratio to receive neoadjuvant chemoradiotherapy with DT45Gy/25f plus

oxaliplatin
capecitabine
immunostimulants
gastrectomy
adjuvant chemotherapy
  • 6 views
  • 22 Jan, 2021
  • 1 location
Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality (GISTAR)

Currently no ideal preventive modalities are available for reducing gastric-cancer caused mortality in organized population-based application. The primary objective of the study is to determine

Accepts healthy volunteers
endoscopy
gastric cancer
cancer
gastritis
  • 21 views
  • 23 Feb, 2022
  • 1 location
Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer (RESCUE-GC)

advanced gastric cancer.

immunostimulants
lymphadenectomy
gastrectomy
adjuvant chemotherapy
cancer chemotherapy
  • 13 views
  • 25 Feb, 2022
  • 5 locations
Trial for Application of Laparoscopic Total Gastrectomy With Lymph Node Dissection for Gastric Cancer (KLASS-06)

Although Laparoscopic gastrectomy for both early and locally advanced gastric cancer has gained popularity, the use of laparoscopic total gastrectomy for proximal advanced gastric cancer is

d2 lymph node dissection
endoscopy
gastric carcinoma
gastrectomy
carcinoma
  • 48 views
  • 02 Mar, 2022
  • 1 location
S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC)

The study aims to compare the efficacy and safety of S-1 for 9 months versus S-1 for 1 year as adjuvant chemotherapy after D2 resection in patients with gastric cancer. Hypothesis: For

immunostimulants
cancer chemotherapy
adjuvant chemotherapy
adenocarcinoma
lymphadenectomy
  • 0 views
  • 07 Feb, 2022
  • 6 locations
Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer

stage gastric cancer as adjuvant setting

oxaliplatin
capecitabine
neutrophil count
platelet count
immunostimulants
  • 0 views
  • 01 Mar, 2022
  • 1 location